While the Guardant360 test is not intended to report germline mutations, we set a VAF cutoff of 40% to identify potential germline GATA3 alterations, which result in HDR syndrome (hypoparathyroidism, deafness, renal dysfunction) [47, 48]. The gene discussed is GATA3; the disease is hypoparathyroidism.